Latest news with #Yangzijiang
Straits Times
07-08-2025
- Business
- Straits Times
Yangzijiang Shipbuilding shares surge 11% on record first-half earnings
Sign up now: Get ST's newsletters delivered to your inbox Yangzijiang Shipbuilding saw a 36,7 per cent jump in net profit to 4.18 billion yuan (S$748 million) for the six months to June 30. SINGAPORE - Shares of Yangzijiang Shipbuilding soared on Aug 7, after the mainboard-listed company posted a record net profit for the first half of 2025. The stock rallied as much as 11 per cent to $2.92 after its results announcement, and was up 7.6 per cent at $2.83 at the midday trading break. A hefty 69.2 million shares changed hands. Yangzijiang saw a 36,7 per cent jump in net profit to 4.18 billion yuan (S$748 million) for the six months ended June 30, from 3.06 billion yuan in the year-ago period. This was despite a 1.3 per cent dip in first half revenue to 12.88 billion yuan, the company reported b efore the market opened on Aug 7 . The decline in revenue was mainly due to lower contributions from the shipbuilding segment, as the group has begun constructing oil tankers, which it said 'carry a lower average unit price than container ships'. Revenue from the shipping segment also fell 15.4 per cent year on year to 511.4 million yuan, following a drop in charter rates. But revenue from its other businesses - including trading, ship design services and investment properties - climbed 153.2 per cent year on year to 117.1 million yuan in the first half of FY2025. Top stories Swipe. Select. Stay informed. Singapore Some ageing condos in Singapore struggle with failing infrastructure, inadequate sinking funds Singapore PUB investigating wastewater discharge in Eunos: Pritam Singapore Water gel guns among newer tools NParks uses to manage monkeys in estates World Trump eyes 100% chips tariff, but 0% for US investors like Apple World Trump's 100% semiconductor tariffs may hit chipmakers in Singapore, other SEA nations Singapore Afraid of small talk? Scared to make a phone call? How social skills workshops are helping young people Singapore ST and Uniqlo launch design contest for Singapore stories T-shirt collection Business DBS shares hit record-high after Q2 profit beats forecast on strong wealth fees, trading income Contributions from Yangzijiang's associated companies and joint ventures rose 79 per cent year on year to 481.4 million yuan. This included 320 million yuan from Yangzi-Mitsui Shipbuilding, and 160 million yuan from Tsuneishi Zhoushan, in which the group completed a capital injection for a 34 per cent stake in the first quarter of 2025. Looking ahead, the company said the shipbuilding industry faces macroeconomic uncertainties and geopolitical tensions in the near term. Global shipbuilding contracted 54 per cent year on year in the first half of 2025, primarily due to growing concerns over the impact of the US tariffs on global trade volumes. Additionally, proposed US port fees have prompted shipowners to seek alternatives, though limited capacity outside China remains a constraint, the Chinese shipbuilder said. Yangzijiang, however, remains 'cautiously optimistic', given its outstanding orderbook. During the first half year, the group secured contracts amounting to US$537.2 million (S$640.5 million) for 14 vessels, with about 85 per cent for container ships. This raised the group's total outstanding order book to US$23.2 billion for delivery through 2029 and beyond. It expects improved market sentiment and clearer tariff progression in the second half of 2025 to support new orders, and is confident of filling its remaining delivery slots for 2028 and 2029, which largely comprise small to mid-sized vessels.
Business Times
06-08-2025
- Business
- Business Times
Yangzijiang Shipbuilding posts record earnings of 4.2 billion yuan for H1
[SINGAPORE] Yangzijiang Shipbuilding posted a record-high net profit of 4.2 billion yuan (S$752.6 million) for the six months ended Jun 30, 2025, marking a 36.7 per cent surge from 3.1 billion yuan for the same period a year earlier. This comes as an associated company has started to contribute meaningfully. In a regulatory filing on Wednesday (Aug 6), the mainboard-listed shipbuilder posted a 1.3 per cent year-on-year drop in revenue for H1 FY2025, to 12.9 billion yuan. The decrease was mainly caused by lower contributions from the shipbuilding segment, as it has begun the construction of oil tankers, which the group said 'carry a lower average unit price than container ships'. There was also a decline in revenue for the shipping segment – down 15.4 per cent year on year to 511.4 million yuan – which Yangzijiang said was due to lower charter rates. However, other businesses, which include trading, ship design services and investment property, contributed 153.2 per cent higher revenue at 117.1 million yuan for H1. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up Contributions from associated companies and joint ventures – including a contribution of 320 million yuan from Yangzi-Mitsui Shipbuilding and 160 million yuan from Tsuneishi Zhoushan – improved by 79 per cent year on year to 481.4 million yuan. Yangzijiang completed its capital injection – for a 34 per cent equity stake – in Tsuneishi Zhoushan in the first quarter of the year. The group recognised a 160 million yuan share of profit from the associated company for H1. The group's net profit margin improved to 32.5 per cent, from 23.4 per cent for the year-ago period; earnings per share rose to 1.0602 yuan from 0.7742 yuan. Net asset value per share stood at 7.048 yuan as at Jun 30, higher than 6.6517 yuan as at Dec 31, 2024. Yangzijiang said that, during H1 FY2025, it clinched contracts amounting to US$537.2 million for 14 vessels, with approximately 85 per cent for container ships. This raised the group's total outstanding order book to US$23.2 billion for delivery through 2029 and beyond. No dividend was declared for the period. Shares of Yangzijiang closed 2.3 per cent or S$0.06 up at S$2.63 on Wednesday, before the results were posted.
Yahoo
08-07-2025
- Business
- Yahoo
Asian Penny Stocks Spotlight: Shengjing Bank And Two Others
As global markets continue to react positively to easing trade tensions and economic developments, investors are exploring diverse opportunities across regions. Penny stocks, though an older term, still capture the essence of investing in smaller or newer companies that may offer significant value at lower price points. By focusing on those with strong financials and growth potential, investors can uncover hidden gems within the Asian market landscape. Name Share Price Market Cap Financial Health Rating Lever Style (SEHK:1346) HK$1.24 HK$782.38M ★★★★★★ Ever Sunshine Services Group (SEHK:1995) HK$2.08 HK$3.6B ★★★★★☆ TK Group (Holdings) (SEHK:2283) HK$2.27 HK$1.89B ★★★★★★ CNMC Goldmine Holdings (Catalist:5TP) SGD0.43 SGD174.27M ★★★★★☆ Goodbaby International Holdings (SEHK:1086) HK$1.13 HK$1.89B ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.24 SGD8.82B ★★★★★☆ Beng Kuang Marine (SGX:BEZ) SGD0.205 SGD41.45M ★★★★★★ BRC Asia (SGX:BEC) SGD3.10 SGD850.49M ★★★★★★ Bosideng International Holdings (SEHK:3998) HK$4.54 HK$52.01B ★★★★★★ United Energy Group (SEHK:467) HK$0.54 HK$13.96B ★★★★★★ Click here to see the full list of 997 stocks from our Asian Penny Stocks screener. Let's uncover some gems from our specialized screener. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Shengjing Bank Co., Ltd. and its subsidiaries provide banking products and financial services in Mainland China, with a market cap of HK$11.17 billion. Operations: The company generates revenue through three main segments: Retail Banking with CN¥1.87 billion, Corporate Banking at CN¥4.67 billion, and Treasury Business contributing CN¥176.56 million. Market Cap: HK$11.17B Shengjing Bank, with a market cap of HK$11.17 billion, operates through Retail Banking (CN¥1.87 billion), Corporate Banking (CN¥4.67 billion), and Treasury Business (CN¥176.56 million). Despite its high-quality earnings and appropriate loan levels, the bank faces challenges with declining profits—down 50% annually over five years—and low return on equity at 0.8%. The management team is experienced but the board lacks tenure depth, reflecting recent changes including Mr. Wang Jun's resignation due to retirement age and upcoming elections for new directors amid restructuring plans for village banks into branches. Click to explore a detailed breakdown of our findings in Shengjing Bank's financial health report. Gain insights into Shengjing Bank's past trends and performance with our report on the company's historical track record. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Guoquan Food (Shanghai) Co., Ltd. operates as a home meal products company in Mainland China with a market cap of HK$8.81 billion. Operations: The company generates revenue primarily from its Retail - Grocery Stores segment, amounting to CN¥6.47 billion. Market Cap: HK$8.81B Guoquan Food (Shanghai), with a market cap of HK$8.81 billion, is expanding its footprint by investing approximately RMB 490 million in a new production base in Hainan Province. Despite negative earnings growth last year and a low return on equity of 7.4%, the company maintains strong financial health with short-term assets exceeding liabilities and more cash than total debt. Recent strategic moves include increasing dividends and appointing Ms. Yang Tongyu as an executive director, reflecting efforts to enhance shareholder value and governance amidst stable weekly volatility at 11%. Earnings are projected to grow by 21.92% annually. Unlock comprehensive insights into our analysis of Guoquan Food (Shanghai) stock in this financial health report. Assess Guoquan Food (Shanghai)'s future earnings estimates with our detailed growth reports. Simply Wall St Financial Health Rating: ★★★★★★ Overview: United Energy Group Limited is an investment holding company involved in upstream oil, natural gas, clean energy, and energy trading operations across Pakistan, South Asia, the Middle East, and North Africa with a market cap of approximately HK$13.96 billion. Operations: The company generates revenue through two primary segments: Trading, which contributes HK$7.66 billion, and Exploration and Production, accounting for HK$9.86 billion. Market Cap: HK$13.96B United Energy Group, with a market cap of HK$13.96 billion, has shown resilience by becoming profitable this year despite a large one-off loss of HK$442.4 million impacting its recent financial results. The company generates substantial revenue from its Trading and Exploration and Production segments, totaling over HK$17 billion combined. While the company's debt is well-covered by operating cash flow, recent leadership changes highlight an evolving governance structure with new appointments in key roles. Despite high share price volatility and significant insider selling recently, United Energy Group trades at a good value compared to industry peers. Click here to discover the nuances of United Energy Group with our detailed analytical financial health report. Review our growth performance report to gain insights into United Energy Group's future. Jump into our full catalog of 997 Asian Penny Stocks here. Contemplating Other Strategies? Outshine the giants: these 22 early-stage AI stocks could fund your retirement. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:2066 SEHK:2517 and SEHK:467. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
07-07-2025
- Business
- Yahoo
Asian Penny Stocks To Monitor In July 2025
As global markets experience varied performances, with the U.S. indices hitting record highs and Japan facing trade negotiation challenges, investors are keenly observing the shifting dynamics in Asia. Amidst these developments, penny stocks—traditionally smaller or newer companies—continue to capture attention for their potential value and growth opportunities. While the term may seem outdated, these stocks still hold relevance as they often represent companies with solid financial foundations that could offer stability and potential upside in a fluctuating market landscape. Name Share Price Market Cap Financial Health Rating Lever Style (SEHK:1346) HK$1.29 HK$813.93M ★★★★★★ Ever Sunshine Services Group (SEHK:1995) HK$2.08 HK$3.6B ★★★★★☆ TK Group (Holdings) (SEHK:2283) HK$2.28 HK$1.9B ★★★★★★ CNMC Goldmine Holdings (Catalist:5TP) SGD0.43 SGD174.27M ★★★★★☆ Goodbaby International Holdings (SEHK:1086) HK$1.14 HK$1.9B ★★★★★★ T.A.C. Consumer (SET:TACC) THB4.42 THB2.65B ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.21 SGD8.7B ★★★★★☆ Ekarat Engineering (SET:AKR) THB0.92 THB1.35B ★★★★★★ Beng Kuang Marine (SGX:BEZ) SGD0.20 SGD40.44M ★★★★★★ BRC Asia (SGX:BEC) SGD3.16 SGD866.95M ★★★★★★ Click here to see the full list of 993 stocks from our Asian Penny Stocks screener. Let's take a closer look at a couple of our picks from the screened companies. Simply Wall St Financial Health Rating: ★★★★★★ Overview: PSG Corporation Public Company Limited, with a market cap of THB14.79 billion, operates in turnkey engineering, procurement, and construction (EPC) and large-scale construction projects in Thailand and the Lao People's Democratic Republic. Operations: The company's revenue is primarily derived from its plant and building construction segment, amounting to THB2.82 billion. Market Cap: THB14.79B PSG Corporation, with a market cap of THB14.79 billion, operates in the EPC and construction sectors in Thailand and Laos. Despite being debt-free and having short-term assets significantly exceeding liabilities, PSG's earnings have declined substantially over the past year, with revenue dropping to THB642.96 million from THB1.49 billion a year ago. The company's net profit margin has also decreased from 51.6% to 26.8%. Recent volatility in share price could be attributed to these financial results and strategic moves like the recent MOU with Electricite du Laos for renewable energy projects, potentially enhancing future growth prospects amidst current challenges. Navigate through the intricacies of PSG Corporation with our comprehensive balance sheet health report here. Evaluate PSG Corporation's historical performance by accessing our past performance report. Simply Wall St Financial Health Rating: ★★★★★★ Overview: CSE Global Limited is an investment holding company that provides integrated industrial automation, information technology, and intelligent transport solutions across the Asia Pacific, the Americas, Europe, the Middle East, and Africa with a market cap of SGD436.54 million. Operations: The company's revenue is derived from three primary segments: Automation (SGD194.36 million), Communications (SGD232.04 million), and Electrification (SGD434.78 million). Market Cap: SGD436.54M CSE Global Limited, with a market cap of SGD436.54 million, shows a stable financial foundation with short-term assets exceeding liabilities and well-covered interest payments by EBIT. Despite experiencing a 5.4% annual decline in earnings over the past five years, recent profit growth of 16.9% signals potential recovery, outpacing industry averages. The company's seasoned management and board add strategic depth, further enhanced by the recent appointment of Mr. Ravinder Singh as Non-Executive Director to bolster governance capabilities. However, dividend sustainability remains questionable due to insufficient free cash flow coverage despite trading below estimated fair value. Click here to discover the nuances of CSE Global with our detailed analytical financial health report. Assess CSE Global's future earnings estimates with our detailed growth reports. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Zhejiang CONBA Pharmaceutical Co., Ltd. focuses on the research, development, production, and sales of pharmaceuticals and health products in mainland China, with a market cap of CN¥11.27 billion. Operations: The company's revenue primarily comes from its operations in China, totaling CN¥6.38 billion. Market Cap: CN¥11.27B Zhejiang CONBA Pharmaceutical Co., Ltd. demonstrates a solid financial position with short-term assets of CN¥4.5 billion surpassing both short and long-term liabilities, and its debt is well-covered by operating cash flow. Despite a slight decline in quarterly revenue to CN¥1.68 billion, the company maintains profitability with net income at CN¥189.4 million and improved profit margins from 8.1% to 9.3%. However, its return on equity remains low at 8.7%, and the board's average tenure suggests inexperience, potentially impacting strategic decisions amidst an unstable dividend track record despite trading below estimated fair value by 16.6%. Dive into the specifics of Zhejiang CONBA PharmaceuticalLtd here with our thorough balance sheet health report. Examine Zhejiang CONBA PharmaceuticalLtd's past performance report to understand how it has performed in prior years. Navigate through the entire inventory of 993 Asian Penny Stocks here. Want To Explore Some Alternatives? We've found 16 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SET:PSG SGX:544 and SHSE:600572. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
01-07-2025
- Business
- Yahoo
Asian Penny Stocks To Watch In July 2025
As global markets celebrate positive developments, such as the U.S. and China signing a new trade deal, Asian indices have also shown resilience and potential for growth. Penny stocks may be an older term, but they continue to represent intriguing opportunities in the investment landscape, particularly within smaller or newer companies. By identifying those with strong financial health and clear growth prospects, investors can uncover potential gems that offer both stability and upside in today's market conditions. Name Share Price Market Cap Financial Health Rating Lever Style (SEHK:1346) HK$1.29 HK$813.93M ★★★★★★ Ever Sunshine Services Group (SEHK:1995) HK$2.04 HK$3.53B ★★★★★☆ TK Group (Holdings) (SEHK:2283) HK$2.27 HK$1.89B ★★★★★★ CNMC Goldmine Holdings (Catalist:5TP) SGD0.435 SGD176.3M ★★★★★☆ Goodbaby International Holdings (SEHK:1086) HK$1.05 HK$1.75B ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.25 SGD8.86B ★★★★★☆ Beng Kuang Marine (SGX:BEZ) SGD0.182 SGD36.26M ★★★★★★ BRC Asia (SGX:BEC) SGD3.12 SGD855.97M ★★★★★★ Bosideng International Holdings (SEHK:3998) HK$4.64 HK$53.16B ★★★★★★ United Energy Group (SEHK:467) HK$0.52 HK$13.44B ★★★★★★ Click here to see the full list of 1,001 stocks from our Asian Penny Stocks screener. Let's review some notable picks from our screened stocks. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: HuBei NengTer Technology Co., Ltd operates an ecommerce platform focused on the supply chain of plastic raw materials in China, with a market cap of CN¥8.82 billion. Operations: Currently, there are no reported revenue segments available for this company. Market Cap: CN¥8.82B HuBei NengTer Technology Ltd., with a market cap of CN¥8.82 billion, recently reported first-quarter sales of CN¥2,877.27 million and net income of CN¥215.9 million, reflecting an improvement from the previous year's figures despite a decline in sales compared to last year. The company has completed a share buyback worth CN¥329.98 million, enhancing shareholder value without significant dilution over the past year. While unprofitable with increasing losses over five years, it maintains sufficient cash runway for more than three years and holds more cash than its total debt, indicating financial stability amidst volatility concerns. Unlock comprehensive insights into our analysis of HuBei NengTer TechnologyLtd stock in this financial health report. Examine HuBei NengTer TechnologyLtd's past performance report to understand how it has performed in prior years. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Tianjin Chase Sun Pharmaceutical Co., Ltd is involved in the research, development, production, and sale of pharmaceutical products both in China and internationally, with a market cap of CN¥11.99 billion. Operations: No specific revenue segments are reported for Tianjin Chase Sun Pharmaceutical Co., Ltd. Market Cap: CN¥11.99B Tianjin Chase Sun Pharmaceutical Co., Ltd, with a market cap of CN¥11.99 billion, reported first-quarter sales of CN¥1.39 billion and net income of CN¥60.33 million, showing slight growth from the previous year despite declining sales figures. The company's short-term assets significantly exceed its liabilities, and it holds more cash than debt, indicating a strong liquidity position. However, profit margins have decreased to 0.4% from 6.6% last year, raising concerns about profitability sustainability amid negative earnings growth over the past year and low return on equity at 0.3%. Recent board changes may influence strategic direction moving forward. Dive into the specifics of Tianjin Chase Sun PharmaceuticalLtd here with our thorough balance sheet health report. Assess Tianjin Chase Sun PharmaceuticalLtd's future earnings estimates with our detailed growth reports. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Hunan Er-Kang Pharmaceutical Co., Ltd is engaged in the manufacturing and sale of APIs, finished drug products, and pharmaceutical excipients both in China and internationally, with a market cap of CN¥6.91 billion. Operations: Hunan Er-Kang Pharmaceutical Co., Ltd has not reported specific revenue segments. Market Cap: CN¥6.91B Hunan Er-Kang Pharmaceutical, with a market cap of CN¥6.91 billion, has shown mixed financial performance. Despite a decline in annual revenue from CN¥1.78 billion to CN¥1.14 billion and an increased net loss of CN¥373.37 million for 2024, the company reported improved first-quarter sales of CN¥353.55 million and net income of CN¥28.11 million in 2025 compared to the previous year. The company's short-term assets exceed both its long-term and short-term liabilities, indicating strong liquidity, yet its negative return on equity and high share price volatility highlight ongoing profitability challenges amid increased debt levels over time. Navigate through the intricacies of Hunan Er-Kang Pharmaceutical with our comprehensive balance sheet health report here. Review our historical performance report to gain insights into Hunan Er-Kang Pharmaceutical's track record. Navigate through the entire inventory of 1,001 Asian Penny Stocks here. Want To Explore Some Alternatives? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SZSE:002102 SZSE:300026 and SZSE:300267. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Errore nel recupero dei dati Effettua l'accesso per consultare il tuo portafoglio Errore nel recupero dei dati
